Back
ESC Premium Access

E3 Trial: The 52-Week Results

Session: Latest Science in CV Prevention
Topic: Tobacco
Speaker: Doctor K. Filion (Montreal, CA)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

0

About the speaker

Doctor Kristian Filion

Montreal (Canada)
1 presentation
0 follower

6 more presentations in this session

Nationwide trends in stroke and atrial fibrillation in patients with incident type 2 diabetes

Speaker: Doctor C. Gyldenkerne (Aarhus, DK)

Access
Slides
Video
0
Thumbnail

CRISP-CT: Incorporating FAI-Score In Clinical Decision Making

Speaker: Professor C. Antoniades (Oxford, GB)

Access
Slides
Video
0
Thumbnail

Opiates and its effects on cardiovascular outcomes

Speaker: Doctor S. Liew (Melbourne, AU)

Access
Slides
Video
0
Thumbnail

Long term effects of the Randomized Evaluation of Secondary Prevention by Outpatient Nurse Specialists-2 trial (RESPONSE-2)

Speaker: Doctor H. Jorstad (Amsterdam, NL)

Access
Slides
Video
0
Thumbnail

Metabolic Surgery and Risk of MACE in NASH

Speaker: Doctor A. Aminian (Cleveland, US)

Access
Slides
Video
0
Thumbnail

Access the full session

Latest Science in CV Prevention

Speakers: Doctor K. Filion, Doctor C. Gyldenkerne, Professor C. Antoniades, Doctor S. Liew, Doctor H. Jorstad...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Future treatments for lipoprotein(a).

27 August 2021

ESC Premium Access

Current treatment for elevated lipoprotein(a).

27 August 2021

ESC Premium Access

Lipoprotein(a) and cardiovascular risk.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk